1. Home
  2. PCRX vs IIPR Comparison

PCRX vs IIPR Comparison

Compare PCRX & IIPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

SELL

Current Price

$36.48

Market Cap

1.5B

Sector

Health Care

ML Signal

SELL

Logo Innovative Industrial Properties Inc.

IIPR

Innovative Industrial Properties Inc.

SELL

Current Price

$52.31

Market Cap

1.5B

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
PCRX
IIPR
Founded
2006
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.5B
IPO Year
2010
2016

Fundamental Metrics

Financial Performance
Metric
PCRX
IIPR
Price
$36.48
$52.31
Analyst Decision
Hold
Buy
Analyst Count
9
7
Target Price
$33.57
★ $62.15
AVG Volume (30 Days)
★ 958.5K
257.8K
Earning Date
11-09-2026
11-02-2026
Dividend Yield
N/A
★ 14.33%
EPS Growth
★ 107.44
N/A
EPS
0.89
★ 3.38
Revenue
★ $541,533,000.00
$265,955,000.00
Revenue This Year
$3.84
N/A
Revenue Next Year
$4.73
N/A
P/E Ratio
$40.96
★ $15.70
Revenue Growth
★ 26.04
N/A
52 Week Low
$18.80
$44.58
52 Week High
$36.67
$65.38

Technical Indicators

Market Signals
Indicator
PCRX
IIPR
Relative Strength Index (RSI) 82.40 42.37
Support Level $22.00 $48.98
Resistance Level $36.67 $57.77
Average True Range (ATR) 0.04 1.47
MACD -0.37 -0.17
Stochastic Oscillator 90.00 6.31

Price Performance

Historical Comparison
PCRX
IIPR

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About IIPR Innovative Industrial Properties Inc.

Innovative Industrial Properties Inc is a real estate investment trust focused on the acquisition, ownership and management of specialized industrial and commercial properties in the United States. Its properties are prominently leased to state-licensed operators for their regulated cannabis facilities. The company conducts its business through a traditional umbrella partnership real estate investment trust, or UPREIT structure, in which properties are owned by its Operating Partnership, directly or through subsidiaries. Its segments are: Cannabis Portfolio and Life Science Portfolio, with the majority of revenue coming from the Cannabis Portfolio segment, which involves acquiring, developing, and leasing real estate to regulated cannabis operators on long-term triple-net leases.

Share on Social Networks: